Conference abstract · 30 Jun 2016
Conference abstractPublished 18 Jul 2016
The solubility-permeability interplay in Formulation Development for Low-Solubility Drugs
Ben-Gurion University of the Negev, Israel
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
While each of the two key parameters of oral drug absorption, the solubility and the permeability, has been comprehensively studied separately, the relationship and interplay between the two has been largely ignored. For instance, when formulating a low-solubility drug, what are the effects on the apparent permeability? The direct correlation between the intestinal permeability and the membrane/aqueous partitioning, which in turn is dependent on the drug's apparent solubility in the GI milieu, suggests that the solubility and the permeability are closely associated, exhibiting certain interplay between them, and the current view of treating the one irrespectively of the other may not be sufficient. In this lecture, our results on this solubility-permeability interplay will be presented. Decreased apparent permeability accompanied the solubility increase when different solubilisation methods are employed; however, increasing the apparent solubility by super saturation e.g. via amorphous solid dispersions, circumvented the solubility-permeability trade-off, and the permeability remained steady. Most recently, even increased permeability was discovered, when the super saturation saturated efflux processes. Overall, the solubility-permeability interplay cannot be ignored when using solubility-enabling formulations; looking solely at the solubility may be misleading with regards to absorption predictions, and hence, the solubility-permeability interplay must be taken into account to strike the optimal solubility–permeability balance, in order to maximize the overall absorption.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2016
Amorphous solid dispersion (ASD)formulation of the low-solubility drug rifaximine allows overcoming the solubility-permeability tradeoff
Conference abstract
Experimental methods to study interplay of dissolution, solubility and permeability in formulation development
Conference abstract · 26 Jun 2017
Developing better formulations for oral lipophilic drugs by accounting for both the solubility and the intestinal permeability
Commentary · 18 Feb 2022
The Solubility Permeability Interplay and Implications in Manufacture Design and Improvement for Poor Soluble Drugs
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Arik Dahan”
